Lindbrook Capital’s Cymabay Therapeutics CBAY Stock Holding History

Lindbrook Capital’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-218	Closed	-$5.15K	–	2773
2023 Q4	$5.15K	Buy	+218	New	+$3.88K	﹤0.01%	1869

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lindbrook Capital's CBAY Position: Q1 2024 in Review

Lindbrook Capital sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 218 shares — an estimated $5.15K sold.

Lindbrook Capital first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $5.15K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Lindbrook Capital reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Lindbrook Capital sold 218 Cymabay Therapeutics shares in Q1 2024, an estimated $5.15K.
Lindbrook Capital first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Lindbrook Capital's Cymabay Therapeutics position peaked at $5.15K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.